Concepedia

Mohammad Akbarzadeh

MA

Statistics

Publications

17

Citations

867

H-Index

13

Active since

2013

Affiliations

Max Planck Institute of Molecular Physiology(Current)

TU Dortmund University

Heinrich Heine University Düsseldorf

AstraZeneca (Sweden)

Lead Discovery Center (Germany)

Mohammad Akbarzadeh is an author at Max Planck Institute of Molecular Physiology specializing in drug discovery, medicinal chemistry, and ligand binding.

Publications per year

2013–2022

17

Publications

17

The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling

Paul Baran, Selina Hansen, Georg H. Waetzig et al. · Journal of Biological Chemistry · 2018 · 223 citations · Full text

, , +15

A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

Michael T. Lam, Simona Coppola, Oliver H.F. Krumbach et al. · The Journal of Experimental Medicine · 2019 · 203 citations · Full text

, , +12

TEAD–YAP Interaction Inhibitors and MDM2 Binders from DNA‐Encoded Indole‐Focused Ugi Peptidomimetics

Verena B. K. Kunig, Marco Potowski, Mohammad Akbarzadeh et al. · Angewandte Chemie International Edition · 2020 · 76 citations · Full text

, , +17

Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket

Hacer Karataş, Mohammad Akbarzadeh, Hélène Adihou et al. · Journal of Medicinal Chemistry · 2020 · 65 citations · Full text

, , +14

Morphological profiling by means of the Cell Painting assay enables identification of tubulin-targeting compounds

Mohammad Akbarzadeh, Ilka Deipenwisch, Beate Schoelermann et al. · Cell chemical biology · 2021 · 56 citations

, , +8

1–5 of 17